Overview
HelixBind’s patent pending Pathogen Identification (PID) platform will provide rapid detection and unequivocal identification of bloodstream infections, direct from a whole blood specimen and without the need for blood culture. This will allow physicians to quickly adjust to the optimal, targeted, antimicrobial intervention and monitor the effectiveness of that treatment throughout care. Together we will change the way infections are treated, improve care, and save lives.